Login / Signup

Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.

Annina H HaverinenKaisu M LuiroTimea SzantoMarika H KangasniemiLeena HiltunenSusanna SainioTerhi T PiltonenRiitta LassilaJuha S TapanainenOskari Heikinheimo
Published in: Acta obstetricia et gynecologica Scandinavica (2022)
Both in vitro and in vivo thrombin generation was lower after exposure to EV + DNG compared with EE + DNG. The lower thrombin generation measures after treatment with EV + DNG indicate less enhancement of coagulation potential and suggest that EV may be favorable to EE as a component of combined oral contraceptives.
Keyphrases
  • estrogen receptor
  • risk assessment
  • human health